NVGN: Novogen

Hey guys. I've traded this beast numerous times and when she goes she goes wild. Today's news of new CEO encouraged me to do a quick look at DD. I strongly believe this company is worth looking at in this $2 area.

Quick rundown:

- Market cap only $37 Million
- Trading very close to cash levels
- New CEO December 9, effective Feb 2016
- Two Phase 1 Trials to start in 2016, until now company is only pre-clinical
- Huge swings in stock price towards $10 three times and down to $1.50-$2 each time
- Currently sitting near all time lows after massive pullback
- Cancer indications makes the stock run on any good news
- I think the enrollment of these trials and/or news could make it spike back to $10 or even higher
- Phase 1 is generally less risky and plenty of cash to mitigate risk in the equation
- End of year position us will to start in and add into any sub $2 dips - get in before it runs

I wrote a short report here: www.james-biotechs.com/swings/

Let me know what you think. I have not validated the science or done a full run through of the filings but seems strong balance sheet, decent catalysts coming and a great opportunity price.

Cheers,

Yelk

P.S. Apologies if they do stem-cell work as well I believe they do some but not all. Could go either forum so put it here.